Jan 11, 2010 at TMCnet - World's Largest Communications and Technology Community

TMCnet: NetApp and Stanford Genome Technology Center Building First Ever Gastric Cancer Registry

By : TMCnet - World's Largest Communications and Technology Community

NetApp, a provider of storage and data management solutions, has stated that their storage technology will power the country’s first ever comprehensive Gastric Cancer registry, which they are building along with Stanford Genome Technology Center, a federally funded, multidisciplinary effort that uses genomic-based approaches to attack fundamental problems in biology and medicine.

Stomach cancer also referred to as Gastric cancer is said to be one of the top cancer killers worldwide and in the US. But Gastric cancer research is also least federal funding of any type of cancer research. NetApp has stated that the new gastric cancer registry is being built with the objective to address the significant need for gastric cancer research. NetApp on its behalf donated more than $600,000 in hardware, software, and service to the Stanford center for gastric cancer research.

Read More
Apr 03, 2013 at Marketwired

Gastric Cancer Foundation Founder, Joseph Peter Gallagher, Loses Battle with Stomach Cancer

By : Marketwired

SAN CARLOS, CA–(Marketwired – Apr 3, 2013) – Joseph Peter (J.P.) Gallagher, passionate advocate of finding a cure for stomach cancer, passed away on February 26 after surviving stomach cancer for five and a half years. He was 43.

J.P. founded the Gastric Cancer Foundation (previously Fund) in 2008 following his initial diagnosis in 2007. Under J.P.’s guidance, GCF has been responsible for funding some of the most important stomach cancer research in the United States. J.P.’s vision will continue under Wayne Feinstein, GCF Board member who will assume J.P.’s role as Chairman.

Read More
Dec 05, 2013 at jWeekly

His son’s bequest; Wayne Feinstein’s personal story

By : jWeekly

A request from his 20-year-old son, Ben, who was dying of stomach cancer, spurred San Mateo resident Wayne Feinstein to commit to whatever he could do to help find a cure for the disease. Last March, about three years after Ben’s tragic passing, Feinstein was elected chair of the board of the Gastric Cancer Foundation, a national nonprofit dedicated to curing stomach and esophageal cancer. Besides fulfilling his promise to Ben, Feinstein says, his dedication to the foundation is grounded in his Jewish responsibility of tikkun olam, or repairing the world, “the same kinds of things that propelled me into Jewish communal service right out of college,” he says. “It’s fundamental to who I am, and this one has a double edge.” Feinstein, 61, spent 18 years in leadership roles at Jewish federations in Detroit, Los Angeles and the Bay Area, where he served as CEO of the S.F.-based Jewish Community Federation and Endowment Fund.

“Every day I think about how I can best honor Ben and everyone who has suffered from stomach cancer. The key to finding a cure is to gain visibility for the disease and invest in research,” Feinstein says. Stomach cancer is the fourth most common cancer worldwide and second leading cause of cancer deaths. Even so, it receives less than 1/2 of 1 percent (0.4 percent) of federal cancer research dollars, according to the foundation’s website. GCF’s annual fundraising gala is Saturday, Dec. 7 at the Peninsula Golf and Country Club in San Mateo. For information or to make a donation, visit http://www.gastriccancer.org.

Read More
Mar 11, 2014 at Medical Xpress

BioPortfolio and MedicalXpress cover the announcement of our new research scholar – Mohammed El-Zaatari

By : Medical Xpress

The American Gastroenterological Association (AGA) Research Foundation and the Gastric Cancer Foundation (GCF) are pleased to announce that the first AGA–Gastric Cancer Foundation Research Scholar Award in Gastric and Esophageal Cancer will support Mohamed El-Zaatari, PhD, from University of Michigan, as he conducts research into the role of myeloid cells in the transition from chronic inflammation to gastric pre-neoplasia.

Gastric (stomach) cancer is a deadly and frequently unheard of cancer. Worldwide, stomach cancer is the fourth most common type of cancer1, and the second leading cause of cancer deaths . In the U.S., gastric cancer is an often-fatal disease with a relative five-year overall survival rate of approximately 27 percent2; and the disease receives just 0.4 percent of federal cancer research dollars3.

Read More
Mar 12, 2014 at Jewish Journal

Following his gut instincts – a beautiful, personal story about Chairman of the Board, Wayne Feinstein and his family

By : Jewish Journal

Benjamin Feinstein, by all accounts, was an exceptional young man. By the time he was a high school senior, his grades assured acceptance to numerous top universities. He also excelled all four years on his high school’s varsity basketball and golf teams, and had a huge and loyal circle of friends who would become extended family for his parents, Wayne and Leslee.

“He had a Ricky Nelson ideal kind of life,” Wayne Feinstein recalled. “Never any problems of any kind until he was stricken with gastric cancer at 17.”

Read More